貴州百靈(002424.SZ):鄭榮辭任財務總監 李紅星繼任
格隆匯12月29日丨貴州百靈(002424.SZ)公佈,公司董事會近日收到公司財務總監鄭榮的書面辭職報吿,鄭榮因身體原因,申請辭去公司財務總監職務,辭任後,鄭榮不再擔任公司任何職務。截至本公吿披露日,鄭榮直接持有公司股票5.13萬股,佔公司總股本的0.0036%,除此之外未通過其他方式持有公司股份。
根據公司發展的需要,經公司董事會提名委員會資格審核,公司於2020年12月29日召開第五屆董事會第九次會議審議通過了《關於財務總監辭職及聘任財務總監的議案》,同意聘任李紅星擔任公司財務總監,任期自本次董事會審議通過之日起至第五屆董事會任期屆滿之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.